| Paolo Gabriel Jorge, MD | |
|
100 E Valencia Mesa Dr Ste 310, Fullerton, CA 92835-3800 | |
| (714) 446-5200 | |
| Not Available |
| Full Name | Paolo Gabriel Jorge |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 11 Years |
| Location | 100 E Valencia Mesa Dr Ste 310, Fullerton, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669891727 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | 55259 (Arizona) | Secondary |
| 2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | A144454 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Jude Medical Center | Fullerton, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Medical Foundation | 8921993205 | 1293 |
News Archive
Prof. Viktor Seledtsov, a senior researcher at the IKBFU Center of Medical Biotechnologies and Alexei von Delwig, a researcher at Innovita Res (Vilnius, Lithuania) have published an article in Expert Review of Vaccines scientific journal.
Health Care Systems, Inc. (HCS) announced today that HCS eMR, Version 4, is 2011/2012 compliant and was certified as an EHR Module on 9/30/2010 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable HOSPITAL certification criteria adopted by the Secretary of Health and Human Services. The 2011/2012 criteria support the Stage 1 meaningful use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).
Data presented today at the European Society of Cardiology Congress demonstrates the effectiveness of a peptide called FX06 in preventing cardiac damage resulting from treatment following a heart attack.
A selection of health policy stories from California, Pennsylvania, Louisiana, Georgia and Oregon.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, noted today that individual site, investigator-initiated results of an ongoing Phase 3 clinical trial of 99m-Tc-Tilmanocept (Lymphoseek) were presented at the American Head and Neck Society's 8th International Conference on Head and Neck Cancer (ICHNC), held in Toronto, July 21-25, 2012.
› Verified 3 days ago
| Entity Name | Providence Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285890624 PECOS PAC ID: 8921993205 Enrollment ID: O20040216001346 |
News Archive
Prof. Viktor Seledtsov, a senior researcher at the IKBFU Center of Medical Biotechnologies and Alexei von Delwig, a researcher at Innovita Res (Vilnius, Lithuania) have published an article in Expert Review of Vaccines scientific journal.
Health Care Systems, Inc. (HCS) announced today that HCS eMR, Version 4, is 2011/2012 compliant and was certified as an EHR Module on 9/30/2010 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable HOSPITAL certification criteria adopted by the Secretary of Health and Human Services. The 2011/2012 criteria support the Stage 1 meaningful use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).
Data presented today at the European Society of Cardiology Congress demonstrates the effectiveness of a peptide called FX06 in preventing cardiac damage resulting from treatment following a heart attack.
A selection of health policy stories from California, Pennsylvania, Louisiana, Georgia and Oregon.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, noted today that individual site, investigator-initiated results of an ongoing Phase 3 clinical trial of 99m-Tc-Tilmanocept (Lymphoseek) were presented at the American Head and Neck Society's 8th International Conference on Head and Neck Cancer (ICHNC), held in Toronto, July 21-25, 2012.
› Verified 3 days ago
| Entity Name | Sharwin Tafazoli Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447806278 PECOS PAC ID: 8729416953 Enrollment ID: O20200320002154 |
News Archive
Prof. Viktor Seledtsov, a senior researcher at the IKBFU Center of Medical Biotechnologies and Alexei von Delwig, a researcher at Innovita Res (Vilnius, Lithuania) have published an article in Expert Review of Vaccines scientific journal.
Health Care Systems, Inc. (HCS) announced today that HCS eMR, Version 4, is 2011/2012 compliant and was certified as an EHR Module on 9/30/2010 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable HOSPITAL certification criteria adopted by the Secretary of Health and Human Services. The 2011/2012 criteria support the Stage 1 meaningful use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).
Data presented today at the European Society of Cardiology Congress demonstrates the effectiveness of a peptide called FX06 in preventing cardiac damage resulting from treatment following a heart attack.
A selection of health policy stories from California, Pennsylvania, Louisiana, Georgia and Oregon.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, noted today that individual site, investigator-initiated results of an ongoing Phase 3 clinical trial of 99m-Tc-Tilmanocept (Lymphoseek) were presented at the American Head and Neck Society's 8th International Conference on Head and Neck Cancer (ICHNC), held in Toronto, July 21-25, 2012.
› Verified 3 days ago
| Entity Name | Pinnacle Pain & Regenerative Medicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578199147 PECOS PAC ID: 6608206305 Enrollment ID: O20200421001222 |
News Archive
Prof. Viktor Seledtsov, a senior researcher at the IKBFU Center of Medical Biotechnologies and Alexei von Delwig, a researcher at Innovita Res (Vilnius, Lithuania) have published an article in Expert Review of Vaccines scientific journal.
Health Care Systems, Inc. (HCS) announced today that HCS eMR, Version 4, is 2011/2012 compliant and was certified as an EHR Module on 9/30/2010 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable HOSPITAL certification criteria adopted by the Secretary of Health and Human Services. The 2011/2012 criteria support the Stage 1 meaningful use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).
Data presented today at the European Society of Cardiology Congress demonstrates the effectiveness of a peptide called FX06 in preventing cardiac damage resulting from treatment following a heart attack.
A selection of health policy stories from California, Pennsylvania, Louisiana, Georgia and Oregon.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, noted today that individual site, investigator-initiated results of an ongoing Phase 3 clinical trial of 99m-Tc-Tilmanocept (Lymphoseek) were presented at the American Head and Neck Society's 8th International Conference on Head and Neck Cancer (ICHNC), held in Toronto, July 21-25, 2012.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paolo Gabriel Jorge, MD 100 E Valencia Mesa Dr Ste 310, Fullerton, CA 92835-3800 Ph: (714) 446-5200 | Paolo Gabriel Jorge, MD 100 E Valencia Mesa Dr Ste 310, Fullerton, CA 92835-3800 Ph: (714) 446-5200 |
News Archive
Prof. Viktor Seledtsov, a senior researcher at the IKBFU Center of Medical Biotechnologies and Alexei von Delwig, a researcher at Innovita Res (Vilnius, Lithuania) have published an article in Expert Review of Vaccines scientific journal.
Health Care Systems, Inc. (HCS) announced today that HCS eMR, Version 4, is 2011/2012 compliant and was certified as an EHR Module on 9/30/2010 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable HOSPITAL certification criteria adopted by the Secretary of Health and Human Services. The 2011/2012 criteria support the Stage 1 meaningful use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).
Data presented today at the European Society of Cardiology Congress demonstrates the effectiveness of a peptide called FX06 in preventing cardiac damage resulting from treatment following a heart attack.
A selection of health policy stories from California, Pennsylvania, Louisiana, Georgia and Oregon.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, noted today that individual site, investigator-initiated results of an ongoing Phase 3 clinical trial of 99m-Tc-Tilmanocept (Lymphoseek) were presented at the American Head and Neck Society's 8th International Conference on Head and Neck Cancer (ICHNC), held in Toronto, July 21-25, 2012.
› Verified 3 days ago
Dr. Paul Chen Lee, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1440 N Harbor Blvd Ste 100, Fullerton, CA 92835 Phone: 855-906-7246 | |
Allison D Jurisch, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1027 N Harbor Blvd # B, Fullerton, CA 92832 Phone: 714-526-3248 Fax: 714-526-3240 | |
Richard Chyan, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 101 E Valencia Mesa Dr, Fullerton, CA 92835 Phone: 714-871-3280 | |
Ms. Robyn Kyomi Sato, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 150 Laguna Rd, Ste A, Fullerton, CA 92835 Phone: 714-738-5525 Fax: 714-738-1352 | |
Mrs. Janell Chiu, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 337 N Wayne Ave, Fullerton, CA 92833 Phone: 714-526-3248 Fax: 714-526-3240 | |
Ketan Patel, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2720 N Harbor Blvd Ste 210, Fullerton, CA 92835 Phone: 714-446-5192 Fax: 714-446-5169 | |
Dr. Sharon Kay Kawai, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1440 N Harbor Blvd, Suite 110, Fullerton, CA 92835 Phone: 714-449-3340 Fax: 714-870-9462 |